The taboo of the Albendazole
This product disables the following:
1. Postmenopausal women;
2. Pregnant or lactating women;
3. Patients with severe renal impairment (creatinine clearance rate <20ml/min);
4. Patients with moderate to severe liver damage;
5. The patient is known to be highly sensitive to albendazole and its preparation excipients.